US2009257974A1PendingUtilityA1
Perfume Compositions
Assignee: GIVAUDAN NEDERLAND SERVICES BPriority: Aug 5, 2006Filed: Aug 3, 2007Published: Oct 15, 2009
Est. expiryAug 5, 2026(~0 yrs left)· nominal 20-yr term from priority
Inventors:Gordon Michael EvansAlan Forbes ProvanDavid Jonathan BradshawJohn Martin BehanKeith Douglas Perring
A01K 1/0152C11B 9/0076C11B 9/0019C11B 9/0084C11B 9/0061C11B 9/003A61L 9/01C11B 9/0034A61L 15/46C11B 9/0015C11B 9/0088C11B 9/0038A61L 2300/216A61L 15/20
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Perfume compositions comprise between 10% and 30% in total by weight of perfume ingredients selected from two groups, Group A, Group B, with the provisos that over 5% but less than 15% of the perfume composition must comprise Group A ingredients, and for compositions comprising less than 10% of Group A ingredients the agregate percentage of Group B ingredients present must be at least equal to the expression 2*/10-A%) where A% is the total percentage of Group A ingredients in the composition.
Claims
exact text as granted — not AI-modified1 . A perfume composition comprising between 10% and 30% in total by weight of perfume ingredients selected from two groups:
Group A, consisting of (3Z)-hex-3-enyl acetate; 3-(1,3-benzodioxol-5-yl)-2-methylpropanal; (3Z)-hex-3-en-1-ol; 1-[4-(methyloxy)phenyl]ethanone; 3-methyl-5-phenylpentan-1-ol; 5-heptyldihydrofuran-2(3H)-one; phenylmethyl acetate; 2-(4-methylcyclohex-3-en-1-yl)propan-2-ol; (3E)-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one; (3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one; 4-hydroxy-3-(methyloxy)benzaldehyde; 1-methyl-3-(2-methylpropyl)cyclohexanol; 7,9-dimethylspiro[5.5]undecan-3-one; perfume 1 being Lavandin AB8381™ ; methyl 2,4-dihydroxy-3,6-dimethylbenzoate; 3,7-dimethyloctan-1-ol; 2-(methyloxy)-4-propylphenol; perfume 2 being Rosenta AB8428™m; 1-{[(1R,2S)-2-(1,1-dimethylethyl)cyclohexyl]oxy}butan-2-ol; perfume 3 being Headspace Freesia AB7254A™; 5-hexyldihydrofuran-2(3H)-one; prop-2-enyl [(2-methylbutyl)oxy]acetate; 1,3-benzodioxole-5-carbaldehyde; [4-(1-methylethyl)cyclohexyl]methanol; 2-hexylcyclopent-2-en-1-one; methyl (2E)-3-phenylprop-2-enoate; 2,6-dimethyloct-7-en-2-ol; 2-methyl-3-[4-(1-methylethyl)phenyl]propanal; and
Group B consisting of 2-phenylethanol; 3,7-dimethyloctan-3-ol (tetrahydro linalol), 2-(methyloxy)-4-[(1E)-prop-1-enyl]phenyl acetate; 4-(methyloxy)benzaldehyde; (2E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-1-one; perfume 4 being Bergamot AB8392™, (3E)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one; cyclopentadecanone; cyclohexadecanolide; prop-2-enyl 3-cyclohexylpropanoate; 3-[3-(1-methylethyl)phenyl]butanal; (3Z)-hex-3-enyl methyl carbonate; (1-methyl-2-{[(1S,3R,5R)-1,2,2-trimethylbicyclo[3.1.0]hex-3-yl]methyl}cyclopropyl)methanol; [3,3-bis(methyloxy)propyl]benzene; perfume 5 being Coumarex I Mod™;
tricyclo[5.2.1.0 {2,6} ]dec-4-en-8-yl propanoate;
with the provisos that offer 5% bat less than 15% of the perfume composition must comprise Group A ingredients, and for compositions comprising less than 10% of Group A ingredients the agregate percentage of Group B ingredients present must be at least
equal to the expression 2*(10-A%) where A% is the total percentage of Group A ingredients in the composition.
2 . A perfume composition according to claim 1 wherein it comprises at least 3, preferably at least 4, most preferably at least 6 Group A ingredients.
3 . A perfume composition according to claim 1 or claim 2 , wherein the Group A ingredients are selected from:
(3)-hex-3-enyl acetate; 3-(1,3-benzodioxol-5yl)-2-methylpropanal; (3Z)-hex-3-en-1-ol; 3-methyl-5-phenylpentan-1-ol; 5-heptyldihydrofuran-2(3H)-one; phenylmethyl acetate; 2-(4-methylcyclohex-3en-1-yl)propan-2-ol; 2,6-dimethyloct-7en-2-ol; (3E)-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one; (3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3en-one; 4-hydoxy-3-(methyloxy)benzaldehyde; 1,3-benzodioxole-5-carbaldehyde.
4 . A method of preventing or ameliorating urine malodour comprising the step of: bringing an effective amount of a composition according to claim 1 into contact with urine or urine residues.
5 . A consumer product comprising a perfume composition according to claim 1 .
6 . A urine malodor preventing or ameliorating article urine malodour, comprising an effective amount of a perfume composition according to claim 1 .
7 . A catamenial article according to claim 6 .
8 . An incontinence control article according to claim 6 .
9 . A method inhibiting the formation of ammonia from urea the method comprising the step of: contacting urea with a perfume composition according to claim 1 .Join the waitlist — get patent alerts
Track US2009257974A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.